Live Vaccines Market, Global Outlook and Forecast 2022-2028

March 2022 | 75 pages | ID: LA3EDF5405C1EN
Market Monitor Global

Abstracts

Live vaccine is bacterium or virus to make its mutation in artificial condition, lose pathogenicity but retain immunogenicity and reproduction ability and remaining virulence, after vaccinating, there is the reproduction or replication of certain level inside human body, resemble a light natural infection process, but won't cause a person to come on.

This report contains market size and forecasts of Live Vaccines in global, including the following market information:

Global Live Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Live Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)

Global top five Live Vaccines companies in 2021 (%)

The global Live Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monovalent Live Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Live Vaccines include Merck, GlaxoSmithKline, Pfizer, Novartis, Astellas Pharma, Emergent BioSolutions and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Live Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Live Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Live Vaccines Market Segment Percentages, by Type, 2021 (%)

• Monovalent Live Vaccines
• Multivalent Live Vaccines

Global Live Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Live Vaccines Market Segment Percentages, by Application, 2021 (%)

• Adults
• Children

Global Live Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)

Global Live Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Live Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Live Vaccines revenues share in global market, 2021 (%)

Key companies Live Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)

Key companies Live Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• GlaxoSmithKline
• Pfizer
• Novartis
• Astellas Pharma
• Emergent BioSolutions
• AstraZeneca

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Live Vaccines Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Live Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LIVE VACCINES OVERALL MARKET SIZE

2.1 Global Live Vaccines Market Size: 2021 VS 2028
2.2 Global Live Vaccines Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Live Vaccines Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Live Vaccines Players in Global Market
3.2 Top Global Live Vaccines Companies Ranked by Revenue
3.3 Global Live Vaccines Revenue by Companies
3.4 Global Live Vaccines Sales by Companies
3.5 Global Live Vaccines Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Live Vaccines Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Live Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Live Vaccines Players in Global Market
  3.8.1 List of Global Tier 1 Live Vaccines Companies
  3.8.2 List of Global Tier 2 and Tier 3 Live Vaccines Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Live Vaccines Market Size Markets, 2021 & 2028
  4.1.2 Monovalent Live Vaccines
  4.1.3 Multivalent Live Vaccines
4.2 By Type - Global Live Vaccines Revenue & Forecasts
  4.2.1 By Type - Global Live Vaccines Revenue, 2017-2022
  4.2.2 By Type - Global Live Vaccines Revenue, 2023-2028
  4.2.3 By Type - Global Live Vaccines Revenue Market Share, 2017-2028
4.3 By Type - Global Live Vaccines Sales & Forecasts
  4.3.1 By Type - Global Live Vaccines Sales, 2017-2022
  4.3.2 By Type - Global Live Vaccines Sales, 2023-2028
  4.3.3 By Type - Global Live Vaccines Sales Market Share, 2017-2028
4.4 By Type - Global Live Vaccines Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Live Vaccines Market Size, 2021 & 2028
  5.1.2 Adults
  5.1.3 Children
5.2 By Application - Global Live Vaccines Revenue & Forecasts
  5.2.1 By Application - Global Live Vaccines Revenue, 2017-2022
  5.2.2 By Application - Global Live Vaccines Revenue, 2023-2028
  5.2.3 By Application - Global Live Vaccines Revenue Market Share, 2017-2028
5.3 By Application - Global Live Vaccines Sales & Forecasts
  5.3.1 By Application - Global Live Vaccines Sales, 2017-2022
  5.3.2 By Application - Global Live Vaccines Sales, 2023-2028
  5.3.3 By Application - Global Live Vaccines Sales Market Share, 2017-2028
5.4 By Application - Global Live Vaccines Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Live Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Live Vaccines Revenue & Forecasts
  6.2.1 By Region - Global Live Vaccines Revenue, 2017-2022
  6.2.2 By Region - Global Live Vaccines Revenue, 2023-2028
  6.2.3 By Region - Global Live Vaccines Revenue Market Share, 2017-2028
6.3 By Region - Global Live Vaccines Sales & Forecasts
  6.3.1 By Region - Global Live Vaccines Sales, 2017-2022
  6.3.2 By Region - Global Live Vaccines Sales, 2023-2028
  6.3.3 By Region - Global Live Vaccines Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Live Vaccines Revenue, 2017-2028
  6.4.2 By Country - North America Live Vaccines Sales, 2017-2028
  6.4.3 US Live Vaccines Market Size, 2017-2028
  6.4.4 Canada Live Vaccines Market Size, 2017-2028
  6.4.5 Mexico Live Vaccines Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Live Vaccines Revenue, 2017-2028
  6.5.2 By Country - Europe Live Vaccines Sales, 2017-2028
  6.5.3 Germany Live Vaccines Market Size, 2017-2028
  6.5.4 France Live Vaccines Market Size, 2017-2028
  6.5.5 U.K. Live Vaccines Market Size, 2017-2028
  6.5.6 Italy Live Vaccines Market Size, 2017-2028
  6.5.7 Russia Live Vaccines Market Size, 2017-2028
  6.5.8 Nordic Countries Live Vaccines Market Size, 2017-2028
  6.5.9 Benelux Live Vaccines Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Live Vaccines Revenue, 2017-2028
  6.6.2 By Region - Asia Live Vaccines Sales, 2017-2028
  6.6.3 China Live Vaccines Market Size, 2017-2028
  6.6.4 Japan Live Vaccines Market Size, 2017-2028
  6.6.5 South Korea Live Vaccines Market Size, 2017-2028
  6.6.6 Southeast Asia Live Vaccines Market Size, 2017-2028
  6.6.7 India Live Vaccines Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Live Vaccines Revenue, 2017-2028
  6.7.2 By Country - South America Live Vaccines Sales, 2017-2028
  6.7.3 Brazil Live Vaccines Market Size, 2017-2028
  6.7.4 Argentina Live Vaccines Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Live Vaccines Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Live Vaccines Sales, 2017-2028
  6.8.3 Turkey Live Vaccines Market Size, 2017-2028
  6.8.4 Israel Live Vaccines Market Size, 2017-2028
  6.8.5 Saudi Arabia Live Vaccines Market Size, 2017-2028
  6.8.6 UAE Live Vaccines Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Live Vaccines Major Product Offerings
  7.1.4 Merck Live Vaccines Sales and Revenue in Global (2017-2022)
  7.1.5 Merck Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Live Vaccines Major Product Offerings
  7.2.4 GlaxoSmithKline Live Vaccines Sales and Revenue in Global (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 Pfizer
  7.3.1 Pfizer Corporate Summary
  7.3.2 Pfizer Business Overview
  7.3.3 Pfizer Live Vaccines Major Product Offerings
  7.3.4 Pfizer Live Vaccines Sales and Revenue in Global (2017-2022)
  7.3.5 Pfizer Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Live Vaccines Major Product Offerings
  7.4.4 Novartis Live Vaccines Sales and Revenue in Global (2017-2022)
  7.4.5 Novartis Key News
7.5 Astellas Pharma
  7.5.1 Astellas Pharma Corporate Summary
  7.5.2 Astellas Pharma Business Overview
  7.5.3 Astellas Pharma Live Vaccines Major Product Offerings
  7.5.4 Astellas Pharma Live Vaccines Sales and Revenue in Global (2017-2022)
  7.5.5 Astellas Pharma Key News
7.6 Emergent BioSolutions
  7.6.1 Emergent BioSolutions Corporate Summary
  7.6.2 Emergent BioSolutions Business Overview
  7.6.3 Emergent BioSolutions Live Vaccines Major Product Offerings
  7.6.4 Emergent BioSolutions Live Vaccines Sales and Revenue in Global (2017-2022)
  7.6.5 Emergent BioSolutions Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Live Vaccines Major Product Offerings
  7.7.4 AstraZeneca Live Vaccines Sales and Revenue in Global (2017-2022)
  7.7.5 AstraZeneca Key News

8 GLOBAL LIVE VACCINES PRODUCTION CAPACITY, ANALYSIS

8.1 Global Live Vaccines Production Capacity, 2017-2028
8.2 Live Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Live Vaccines Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 LIVE VACCINES SUPPLY CHAIN ANALYSIS

10.1 Live Vaccines Industry Value Chain
10.2 Live Vaccines Upstream Market
10.3 Live Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Live Vaccines Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Live Vaccines in Global Market
Table 2. Top Live Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Live Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Live Vaccines Revenue Share by Companies, 2017-2022
Table 5. Global Live Vaccines Sales by Companies, (K Doses), 2017-2022
Table 6. Global Live Vaccines Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Live Vaccines Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Live Vaccines Product Type
Table 9. List of Global Tier 1 Live Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Live Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Live Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Live Vaccines Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Live Vaccines Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Live Vaccines Sales (K Doses), 2017-2022
Table 15. By Type - Global Live Vaccines Sales (K Doses), 2023-2028
Table 16. By Application – Global Live Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Live Vaccines Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Live Vaccines Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Live Vaccines Sales (K Doses), 2017-2022
Table 20. By Application - Global Live Vaccines Sales (K Doses), 2023-2028
Table 21. By Region – Global Live Vaccines Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Live Vaccines Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Live Vaccines Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Live Vaccines Sales (K Doses), 2017-2022
Table 25. By Region - Global Live Vaccines Sales (K Doses), 2023-2028
Table 26. By Country - North America Live Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Live Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Live Vaccines Sales, (K Doses), 2017-2022
Table 29. By Country - North America Live Vaccines Sales, (K Doses), 2023-2028
Table 30. By Country - Europe Live Vaccines Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Live Vaccines Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Live Vaccines Sales, (K Doses), 2017-2022
Table 33. By Country - Europe Live Vaccines Sales, (K Doses), 2023-2028
Table 34. By Region - Asia Live Vaccines Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Live Vaccines Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Live Vaccines Sales, (K Doses), 2017-2022
Table 37. By Region - Asia Live Vaccines Sales, (K Doses), 2023-2028
Table 38. By Country - South America Live Vaccines Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Live Vaccines Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Live Vaccines Sales, (K Doses), 2017-2022
Table 41. By Country - South America Live Vaccines Sales, (K Doses), 2023-2028
Table 42. By Country - Middle East & Africa Live Vaccines Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Live Vaccines Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Live Vaccines Sales, (K Doses), 2017-2022
Table 45. By Country - Middle East & Africa Live Vaccines Sales, (K Doses), 2023-2028
Table 46. Merck Corporate Summary
Table 47. Merck Live Vaccines Product Offerings
Table 48. Merck Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. GlaxoSmithKline Corporate Summary
Table 50. GlaxoSmithKline Live Vaccines Product Offerings
Table 51. GlaxoSmithKline Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Live Vaccines Product Offerings
Table 54. Pfizer Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. Novartis Corporate Summary
Table 56. Novartis Live Vaccines Product Offerings
Table 57. Novartis Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Astellas Pharma Corporate Summary
Table 59. Astellas Pharma Live Vaccines Product Offerings
Table 60. Astellas Pharma Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Emergent BioSolutions Corporate Summary
Table 62. Emergent BioSolutions Live Vaccines Product Offerings
Table 63. Emergent BioSolutions Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. AstraZeneca Corporate Summary
Table 65. AstraZeneca Live Vaccines Product Offerings
Table 66. AstraZeneca Live Vaccines Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Live Vaccines Production Capacity (K Doses) of Key Manufacturers in Global Market, 2020-2022 (K Doses)
Table 68. Global Live Vaccines Capacity Market Share of Key Manufacturers, 2020-2022
Table 69. Global Live Vaccines Production by Region, 2017-2022 (K Doses)
Table 70. Global Live Vaccines Production by Region, 2023-2028 (K Doses)
Table 71. Live Vaccines Market Opportunities & Trends in Global Market
Table 72. Live Vaccines Market Drivers in Global Market
Table 73. Live Vaccines Market Restraints in Global Market
Table 74. Live Vaccines Raw Materials
Table 75. Live Vaccines Raw Materials Suppliers in Global Market
Table 76. Typical Live Vaccines Downstream
Table 77. Live Vaccines Downstream Clients in Global Market
Table 78. Live Vaccines Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Live Vaccines Segment by Type
Figure 2. Live Vaccines Segment by Application
Figure 3. Global Live Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Live Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Live Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. Live Vaccines Sales in Global Market: 2017-2028 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Live Vaccines Revenue in 2021
Figure 9. By Type - Global Live Vaccines Sales Market Share, 2017-2028
Figure 10. By Type - Global Live Vaccines Revenue Market Share, 2017-2028
Figure 11. By Type - Global Live Vaccines Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Live Vaccines Sales Market Share, 2017-2028
Figure 13. By Application - Global Live Vaccines Revenue Market Share, 2017-2028
Figure 14. By Application - Global Live Vaccines Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Live Vaccines Sales Market Share, 2017-2028
Figure 16. By Region - Global Live Vaccines Revenue Market Share, 2017-2028
Figure 17. By Country - North America Live Vaccines Revenue Market Share, 2017-2028
Figure 18. By Country - North America Live Vaccines Sales Market Share, 2017-2028
Figure 19. US Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Live Vaccines Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Live Vaccines Sales Market Share, 2017-2028
Figure 24. Germany Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. France Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Live Vaccines Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Live Vaccines Sales Market Share, 2017-2028
Figure 33. China Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. India Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Live Vaccines Revenue Market Share, 2017-2028
Figure 39. By Country - South America Live Vaccines Sales Market Share, 2017-2028
Figure 40. Brazil Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Live Vaccines Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Live Vaccines Sales Market Share, 2017-2028
Figure 44. Turkey Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Live Vaccines Revenue, (US$, Mn), 2017-2028
Figure 48. Global Live Vaccines Production Capacity (K Doses), 2017-2028
Figure 49. The Percentage of Production Live Vaccines by Region, 2021 VS 2028
Figure 50. Live Vaccines Industry Value Chain
Figure 51. Marketing Channels